1 / 6

Cancer Biological Therapy Market share forecast to exceed $100bn by 2023

Get more details @ http://bit.ly/2jXllbq <br>Companies are focusing on innovative products with minimum adverse effects, as well as targeting emerging applications to leverage growth opportunities. They are concentrating their efforts on R&D in order to invent novel drugs.

jueekate
Download Presentation

Cancer Biological Therapy Market share forecast to exceed $100bn by 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Cancer Biological Therapy Industry to reach USD 100 billion by 2023: Fractovia.org Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights of Cancer Biological Therapy Market: • Global Cancer Biological Therapy Market size contribution was $61.4 billion for 2015 with overall revenue predicted to surpass $101 billion during forecast period with CAGR of more than 6.1%. • Increase in proportion of different kinds of cancers and rising acceptance of biological treatment is predicted to drive global cancer biological therapy industry trends. • As per WHO reports, proportion of new cases of cancer are expected to increase by 70.1% in future and the reason for this being enhanced consumption of alcohol and tobacco. Increase in aging population all across the globe is projected to fuel global biological cancer therapy industry due to correlation between aging and new cases. • High treatment cost of cancer therapy is mainly owing to high price of medicines. Lot of expenditure is incurred on recognizing and designing a medicine, acquiring preclinical information and clinical trials. • It is also forecast that each medicine costs more than $1.2 billion. Drug monopoly is yet another factor adding to high medicine price.

  3. Continued… • Global cancer biological therapy industry was segmented into products like cytokines, monoclonal antibodies, blood cell growth factors, monoclonal antibodies and vaccines. Monoclonal antibodies segment contributed more than $21.1 billion for 2015. • Antibody treatment is the most significant and successful approach used for treating solid burns as well as hematological malignance. This is one of the reason for the segment growth. • This segment is sub -segmented into bi-specific monoclonal antibodies, naked monoclonal antibodies and conjugated monoclonal antibodies. Bi-specific monoclonal antibodies sub-segment is predicted to register CAGR of 6.51% during forecast timeline. • Vaccines segment is projected to record CAGR of about 17.3% during forecast timeline. Preventive vaccines for HPV (Human papillomavirus) and HBV (Hepatitis B Virus) can encourage antibody production that binds to microbes and block their ability to proliferate & cause infection.

  4. U.S. Cancer Biological Therapy Market size, by product, 2012 - 2023 (USD Million)

  5. Browse Full Market Research Report Cancer Biological Therapy Market @ http://bit.ly/2jTmBgO Request for a Sample of this Research report @ https://www.fractovia.org/request-sample/161

  6. Stay In Touch Website: https://www.fractovia.org Social Media:

More Related